The developing schistosome worms elicit distinct immune responses in different tissue regions

Immunology and Cell Biology

Volumn 91, Issue 7, 2013, Pages 477-485

  McWilliam, Hamish E G ^a   Driguez, Patrick ^b   Piedrafita, David ^a   Maupin, Kevin A ^c   Haab, Brian B ^c   McManus, Donald P ^b   Meeusen, Els N T ^a  

^a MONASH UNIVERSITY   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

antibody response; helminth; migrating larvae; schistosomiasis; vaccine development

Indexed keywords

ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; LUNG; LYMPH NODE; NONHUMAN; PARASITE DEVELOPMENT; RAT; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SKIN; SPLEEN; SUPERNATANT; WESTERN BLOTTING;

RATTUS; SCHISTOSOMA; SCHISTOSOMA JAPONICUM; VERMES;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CELLS, CULTURED; EPITOPES; FEMALE; HUMANS; IMMUNITY, HUMORAL; LARVA; LIVER; LUNG; LYMPH NODES; ORGAN SPECIFICITY; RATS; RATS, WISTAR; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SKIN;

EID: 84881478219     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2013.33     Document Type: Article

References (47)

1. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD et al. Control of neglected tropical diseases. N Engl J Med 2007; 357: 1018-1027. (Pubitemid 47367081)
2. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006; 6: 411-425. (Pubitemid 43949139)
3. King CH. Parasites and poverty: the case of schistosomiasis. Acta Trop 2010; 113: 95-104.
4. McManus DP, Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev 2008; 21: 225-242. (Pubitemid 351160017)
5. Utzinger J, Bergquist R, Olveda R, Zhou XN. Important helminth infections in Southeast Asia diversity, potential for control and prospects for elimination. Adv Parasitol 2010; 72: 1-30.
6. Hotez PJ, Bethony JM, Diemert DJ, Pearson M, Loukas A. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol 2010; 8: 814-826.
7. McManus DP, Gray DJ, Li Y, Feng Z, Williams GM, Stewart D et al. Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam. Clin Microbiol Rev 2010; 23: 442-466.
8. Simpson AJ. Schistosome surface antigens: developmental expression and immuno-logical function. Parasitol Today 1990; 6: 40-45.
9. Gobert GN, Tran MH, Moertel L, Mulvenna J, Jones MK, McManus DP et al. Transcriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytes. PLoS Negl Trop Dis 2010; 4: e600.
10. Capron A, Dessaint JP, Capron M, Ouma JH, Butterworth AE. Immunity to schisto-somes: progress toward vaccine. Science 1987; 238: 1065-1072. (Pubitemid 18011946)
11. Bickle QD. Radiation-attenuated schistosome vaccination-a brief historical perspective. Parasitology 2009; 136: 1621-1632.
12. Mountford AP, Harrop R, Wilson RA. Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma interferon secretion by lymphocytes from mice vaccinated with attenuated larvae. Infect Immun 1995; 63: 1980-1986.
13. McWilliam HEG, Driguez P, Piedrafita D, McManus DP, Meeusen ENT. Novel immunomic technologies for schistosome vaccine development. Parasite Immunol 2012; 34: 276-284.
14. Capron M, Capron A. Rats, mice and men-models for immune effector mechanisms against schistosomiasis. Parasitol Today 1986; 2: 69-75. (Pubitemid 17035851)
15. Hu Y, Lu W, Shen Y, Xu Y, Yuan Z, Zhang C et al. Immune changes of Schistosoma japonicum infections in various rodent disease models. Exp Parasitol 2012; 131: 180-189.
16. Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol 2002; 2: 499-511. (Pubitemid 37328741)
17. Meeusen E, Brandon M. The use of antibody-secreting cell probes to reveal tissue-restricted immune responses during infection. Eur J Immunol 1994; 24: 469-474. (Pubitemid 24041142)
18. Meeusen EN, Brandon MR. Antibody secreting cells as specific probes for antigen identification. J Immunol Methods 1994; 172: 71-76. (Pubitemid 24182203)
19. Cetre C, Pierrot C, Cocude C, Lafitte S, Capron A, Capron M et al. Profiles of Th1 and Th2 cytokines after primary and secondary infection by Schistosoma mansoni in the semipermissive rat host. Infect Immun 1999; 67: 2713-2719. (Pubitemid 29244682)
20. Kariuki TM, Farah IO, Wilson RA, Coulson PS. Antibodies elicited by the secretions from schistosome cercariae and eggs are predominantly against glycan epitopes. Parasite Immunol 2008; 30: 554-562.
21. Porter A, Yue T, Heeringa L, Day S, Suh E, Haab BB. A motif-based analysis of glycan array data to determine the specificities of glycan-binding proteins. Glycobiology 2010; 20: 369-380.
22. Nossal GJ, Makela O. Autoradiographic studies on the immune response. I. The kinetics of plasma cell proliferation. J Exp Med 1962; 115: 209-230.
23. Balic A, Bowles VM, Liu YS, Meeusen EN. Local immune responses in sensitized sheep following challenge infection with Teladorsagia circumcincta. Parasite Immunol 2003; 25: 375-381. (Pubitemid 38019281)
24. Usawattanakul W, Kamijo T, Kojima S. Comparison of recovery of schistosomula of Schistosoma japonicum from lungs of mice and rats. J Parasitol 1982; 68: 783-790. (Pubitemid 13214826)
25. 75Se-methionine-labeled Schistosoma japonicum in normal and immunized mice. J Infect Dis 1992; 166: 1133-1138.
26. Gui M, Kusel JR, Shi YE, Ruppel A. Schistosoma japonicum and S. mansoni: comparison of larval migration patterns in mice. J Helminthol 1995; 69: 19-25.
27. Pearce EJ. Priming of the immune response by schistosome eggs. Parasite Immunol 2005; 27: 265-270. (Pubitemid 41344618)
28. Grzych JM, Pearce E, Cheever A, Caulada ZA, Caspar P, Heiny S et al. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistomiasis mansoni. J Immunol 1991; 146: 1322-1327.
29. Cardoso FC, Pacifico RN, Mortara RA, Oliveira SC. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. Clin Exp Immunol 2006; 144: 382-391. (Pubitemid 43799920)
30. Grzych JM, Capron M, Bazin H, Capron A. In vitro and in vivo effector function of rat IgG2a monoclonal anti-S. mansoni antibodies. J Immunol 1982; 129: 2739-2743. (Pubitemid 13245553)
31. Capron M, Capron A, Torpier G, Bazin H, Bout D, Joseph M. Eosinophil-dependent cytotoxicity in rat schistosomiasis. Involvement of IgG2a antibody and role of mast cells. Eur J Immunol 1978; 8: 127-133. (Pubitemid 8327028)
32. Ford MJ, Dissous C, Pierce RJ. The isotypes of antibody responsible for the 'late' passive transfer of immunity in rats vaccinated with highly irradiated cercariae. Parasitology 1987; 94: 509-522. (Pubitemid 17119820)
33. Grzych JM, Capron M, Dissous C, Capron A. Blocking activity of rat monoclonal antibodies in experimental schistosomiasis. J Immunol 1984; 133: 998-1004. (Pubitemid 14093501)
34. Meeusen EN. Exploiting mucosal surfaces for the development of mucosal vaccines. Vaccine 2011; 29: 8506-8511.
35. Matzinger P, Kamala T. Tissue-based class control: the other side of tolerance. Nat Rev Immunol 2011; 11: 221-230.
36. Skelly PJ, Wilson A. Making sense of the schistosome surface. Adv Parasitol 2006; 63: 185-284. (Pubitemid 44666968)
37. Wang L, Li YL, Fishelson Z, Kusel JR, Ruppel A. Schistosoma japonicum migration through mouse skin compared histologically and immunologically with S. mansoni. Parasitol Res 2005; 95: 218-223. (Pubitemid 40379275)
38. Eberl M, Langermans JAM, Vervenne RA, Nyame AK, Cummings RD, Thomas AW et al. Antibodies to glycans dominate the host response to schistosome larvae and eggs: Is their role protective or subversive? J Infect Dis 2001; 183: 1238-1247. (Pubitemid 32281563)
39. Nyame AK, Lewis FA, Doughty BL, Correa-Oliveira R, Cummings RD. Immunity to schistosomiasis: glycans are potential antigenic targets for immune intervention. Exp Parasitol 2003; 104: 1-13. (Pubitemid 41123180)
40. Nyame AK, Kawar ZS, Cummings RD. Antigenic glycans in parasitic infections: implications for vaccines and diagnostics. Arch Biochem Biophys 2004; 426: 182-200. (Pubitemid 38680616)
41. Hokke CH, Deelder AM. Schistosome glycoconjugates in host-parasite interplay. Glycoconj J 2001; 18: 573-587. (Pubitemid 35341854)
42. Khoo KH. Structural variations in schistosomal glycans. Trends Glycosci Glycotechnol 2001; 13: 493-505.
43. van Diepen A, Smit CH, van Egmond L, Kabatereine NB, Pinot de Moira A, Dunne DW et al. Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray. PLoS Negl Trop Dis 2012; 6: e1922.
44. Wilson RA. Proteomics at the schistosome-mammalian host interface: any prospects for diagnostics or vaccines? Parasitology 2012; 139: 1178-1194.
45. Wang W, Kirschfink M, Ruppel A. Schistosoma japonicum and S. mansoni cercariae: different effects of protein in medium, of mechanical stress, and of an intact complement system on in vitro transformation to schistosomula. Parasitol Res 2006; 99: 269-274. (Pubitemid 44015110)
46. Gobert GN, Moertel L, Brindley PJ, McManus DP. Developmental gene expression profiles of the human pathogen Schistosoma japonicum. BMC Genom 2009; 10: 128.
47. You H, Zhang W, Jones MK, Gobert GN, Mulvenna J, Rees G et al. Cloning and characterisation of Schistosoma japonicum insulin receptors. PLoS One 2010; 5: e9868.